Home LiteratureArticle Details
PMID: 11905811 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Review

How can immunology contribute to the control of tuberculosis?

Nature reviews. Immunology ·Vol. 1 ·No. 1 ·2001-10-00 ·Pages 20-30

Kaufmann SH

Abstract

Tuberculosis poses a significant threat to mankind. Multidrug-resistant strains are on the rise, and Mycobacterium tuberculosis infection is often associated with human immunodeficiency virus infection. Satisfactory control of tuberculosis can only be achieved using a highly efficacious vaccine. Tuberculosis is particularly challenging for the immune system. The intracellular location of the pathogen shields it from antibodies, and a variety of T-cell subpopulations must be activated to challenge the bacterium's resistance to antibacterial defence mechanisms. A clear understanding of the immune responses that control the pathogen will be important for achieving optimal immunity, and information provided by functional genome analysis of M. tuberculosis will be vital in the design of a future vaccine.

MeSH Terms
Animals BCG Vaccine/isolation & purification,pharmacology Disease Models, Animal Humans Mice Models, Immunological Mycobacterium tuberculosis/genetics,growth & development,immunology,pathogenicity T-Lymphocytes/immunology Tuberculosis/immunology,prevention & control
Chemicals
BCG Vaccine
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Kaufmann S H
Max-Planck-Institute for Infection Biology, Department of Immunology, Berlin, Germany. kaufmann@mpiib-berlin.mpg.de
Article Info
Journal
Nature reviews. Immunology
Abbr.
Nat Rev Immunol
ISSN
1474-1733
Published
2001-10-00
Pages
20-30
Language
English
Region
England
NLM ID
101124169
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com